Symptom-based early-stage differentiation between SARS-CoV-2 versus other respiratory tract infections—Upper Silesia pilot study

Abstract In the DECODE project, data were collected from 3,114 surveys filled by symptomatic patients RT-qPCR tested for SARS-CoV-2 in a single university centre in March-September 2020. The population demonstrated balanced sex and age with 759 SARS-CoV-2( +) patients. The most discriminative sympto...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Justyna Mika, Joanna Tobiasz, Joanna Zyla, Anna Papiez, Małgorzata Bach, Aleksandra Werner, Michał Kozielski, Mateusz Kania, Aleksandra Gruca, Damian Piotrowski, Barbara Sobala-Szczygieł, Bożena Włostowska, Paweł Foszner, Marek Sikora, Joanna Polanska, Jerzy Jaroszewicz
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/c9873397e3a945eeae1a622bdf8cc0c7
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:c9873397e3a945eeae1a622bdf8cc0c7
record_format dspace
spelling oai:doaj.org-article:c9873397e3a945eeae1a622bdf8cc0c72021-12-02T14:34:03ZSymptom-based early-stage differentiation between SARS-CoV-2 versus other respiratory tract infections—Upper Silesia pilot study10.1038/s41598-021-93046-62045-2322https://doaj.org/article/c9873397e3a945eeae1a622bdf8cc0c72021-06-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-93046-6https://doaj.org/toc/2045-2322Abstract In the DECODE project, data were collected from 3,114 surveys filled by symptomatic patients RT-qPCR tested for SARS-CoV-2 in a single university centre in March-September 2020. The population demonstrated balanced sex and age with 759 SARS-CoV-2( +) patients. The most discriminative symptoms in SARS-CoV-2( +) patients at early infection stage were loss of taste/smell (OR = 3.33, p < 0.0001), body temperature above 38℃ (OR = 1.67, p < 0.0001), muscle aches (OR = 1.30, p = 0.0242), headache (OR = 1.27, p = 0.0405), cough (OR = 1.26, p = 0.0477). Dyspnea was more often reported among SARS-CoV-2(-) (OR = 0.55, p < 0.0001). Cough and dyspnea were 3.5 times more frequent among SARS-CoV-2(-) (OR = 0.28, p < 0.0001). Co-occurrence of cough, muscle aches, headache, loss of taste/smell (OR = 4.72, p = 0.0015) appeared significant, although co-occurrence of two symptoms only, cough and loss of smell or taste, means OR = 2.49 (p < 0.0001). Temperature > 38℃ with cough was most frequent in men (20%), while loss of taste/smell with cough in women (17%). For younger people, taste/smell impairment is sufficient to characterise infection, whereas in older patients co-occurrence of fever and cough is necessary. The presented study objectifies the single symptoms and interactions significance in COVID-19 diagnoses and demonstrates diverse symptomatology in patient groups.Justyna MikaJoanna TobiaszJoanna ZylaAnna PapiezMałgorzata BachAleksandra WernerMichał KozielskiMateusz KaniaAleksandra GrucaDamian PiotrowskiBarbara Sobala-SzczygiełBożena WłostowskaPaweł FosznerMarek SikoraJoanna PolanskaJerzy JaroszewiczNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-13 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Justyna Mika
Joanna Tobiasz
Joanna Zyla
Anna Papiez
Małgorzata Bach
Aleksandra Werner
Michał Kozielski
Mateusz Kania
Aleksandra Gruca
Damian Piotrowski
Barbara Sobala-Szczygieł
Bożena Włostowska
Paweł Foszner
Marek Sikora
Joanna Polanska
Jerzy Jaroszewicz
Symptom-based early-stage differentiation between SARS-CoV-2 versus other respiratory tract infections—Upper Silesia pilot study
description Abstract In the DECODE project, data were collected from 3,114 surveys filled by symptomatic patients RT-qPCR tested for SARS-CoV-2 in a single university centre in March-September 2020. The population demonstrated balanced sex and age with 759 SARS-CoV-2( +) patients. The most discriminative symptoms in SARS-CoV-2( +) patients at early infection stage were loss of taste/smell (OR = 3.33, p < 0.0001), body temperature above 38℃ (OR = 1.67, p < 0.0001), muscle aches (OR = 1.30, p = 0.0242), headache (OR = 1.27, p = 0.0405), cough (OR = 1.26, p = 0.0477). Dyspnea was more often reported among SARS-CoV-2(-) (OR = 0.55, p < 0.0001). Cough and dyspnea were 3.5 times more frequent among SARS-CoV-2(-) (OR = 0.28, p < 0.0001). Co-occurrence of cough, muscle aches, headache, loss of taste/smell (OR = 4.72, p = 0.0015) appeared significant, although co-occurrence of two symptoms only, cough and loss of smell or taste, means OR = 2.49 (p < 0.0001). Temperature > 38℃ with cough was most frequent in men (20%), while loss of taste/smell with cough in women (17%). For younger people, taste/smell impairment is sufficient to characterise infection, whereas in older patients co-occurrence of fever and cough is necessary. The presented study objectifies the single symptoms and interactions significance in COVID-19 diagnoses and demonstrates diverse symptomatology in patient groups.
format article
author Justyna Mika
Joanna Tobiasz
Joanna Zyla
Anna Papiez
Małgorzata Bach
Aleksandra Werner
Michał Kozielski
Mateusz Kania
Aleksandra Gruca
Damian Piotrowski
Barbara Sobala-Szczygieł
Bożena Włostowska
Paweł Foszner
Marek Sikora
Joanna Polanska
Jerzy Jaroszewicz
author_facet Justyna Mika
Joanna Tobiasz
Joanna Zyla
Anna Papiez
Małgorzata Bach
Aleksandra Werner
Michał Kozielski
Mateusz Kania
Aleksandra Gruca
Damian Piotrowski
Barbara Sobala-Szczygieł
Bożena Włostowska
Paweł Foszner
Marek Sikora
Joanna Polanska
Jerzy Jaroszewicz
author_sort Justyna Mika
title Symptom-based early-stage differentiation between SARS-CoV-2 versus other respiratory tract infections—Upper Silesia pilot study
title_short Symptom-based early-stage differentiation between SARS-CoV-2 versus other respiratory tract infections—Upper Silesia pilot study
title_full Symptom-based early-stage differentiation between SARS-CoV-2 versus other respiratory tract infections—Upper Silesia pilot study
title_fullStr Symptom-based early-stage differentiation between SARS-CoV-2 versus other respiratory tract infections—Upper Silesia pilot study
title_full_unstemmed Symptom-based early-stage differentiation between SARS-CoV-2 versus other respiratory tract infections—Upper Silesia pilot study
title_sort symptom-based early-stage differentiation between sars-cov-2 versus other respiratory tract infections—upper silesia pilot study
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/c9873397e3a945eeae1a622bdf8cc0c7
work_keys_str_mv AT justynamika symptombasedearlystagedifferentiationbetweensarscov2versusotherrespiratorytractinfectionsuppersilesiapilotstudy
AT joannatobiasz symptombasedearlystagedifferentiationbetweensarscov2versusotherrespiratorytractinfectionsuppersilesiapilotstudy
AT joannazyla symptombasedearlystagedifferentiationbetweensarscov2versusotherrespiratorytractinfectionsuppersilesiapilotstudy
AT annapapiez symptombasedearlystagedifferentiationbetweensarscov2versusotherrespiratorytractinfectionsuppersilesiapilotstudy
AT małgorzatabach symptombasedearlystagedifferentiationbetweensarscov2versusotherrespiratorytractinfectionsuppersilesiapilotstudy
AT aleksandrawerner symptombasedearlystagedifferentiationbetweensarscov2versusotherrespiratorytractinfectionsuppersilesiapilotstudy
AT michałkozielski symptombasedearlystagedifferentiationbetweensarscov2versusotherrespiratorytractinfectionsuppersilesiapilotstudy
AT mateuszkania symptombasedearlystagedifferentiationbetweensarscov2versusotherrespiratorytractinfectionsuppersilesiapilotstudy
AT aleksandragruca symptombasedearlystagedifferentiationbetweensarscov2versusotherrespiratorytractinfectionsuppersilesiapilotstudy
AT damianpiotrowski symptombasedearlystagedifferentiationbetweensarscov2versusotherrespiratorytractinfectionsuppersilesiapilotstudy
AT barbarasobalaszczygieł symptombasedearlystagedifferentiationbetweensarscov2versusotherrespiratorytractinfectionsuppersilesiapilotstudy
AT bozenawłostowska symptombasedearlystagedifferentiationbetweensarscov2versusotherrespiratorytractinfectionsuppersilesiapilotstudy
AT pawełfoszner symptombasedearlystagedifferentiationbetweensarscov2versusotherrespiratorytractinfectionsuppersilesiapilotstudy
AT mareksikora symptombasedearlystagedifferentiationbetweensarscov2versusotherrespiratorytractinfectionsuppersilesiapilotstudy
AT joannapolanska symptombasedearlystagedifferentiationbetweensarscov2versusotherrespiratorytractinfectionsuppersilesiapilotstudy
AT jerzyjaroszewicz symptombasedearlystagedifferentiationbetweensarscov2versusotherrespiratorytractinfectionsuppersilesiapilotstudy
_version_ 1718391158069002240